[artículo] 
inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 683-687

Título :	Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-alzheimer's disease trial
Tipo de documento:	texto impreso
Autores:	Alette M. Wessels, Autor ; Bruce G. Pollock, Autor ; Norbert G. Anyama, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 683-687
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Enfermedad de Alzheimer, Suspensión del tratamiento, 9-OH risperidona
Resumen:	Risperidone has been used to treat behavioral symptoms, such as delusions and agitation, in people with Alzheimer's disease. The relationship between magnitude and variability of risperidone and 9-hydroxy risperidone exposure and the relationship with time to discontinuation of the medication were explored.
Link:	./index.php?lvl=notice_display&id=29416

[artículo] Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-alzheimer's disease trial [texto impreso] / Alette M. Wessels, Autor ; Bruce G. Pollock, Autor ; Norbert G. Anyama, Autor . - 2022 . - pp. 683-687.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 683-687

Palabras clave:	Enfermedad de Alzheimer, Suspensión del tratamiento, 9-OH risperidona
Resumen:	Risperidone has been used to treat behavioral symptoms, such as delusions and agitation, in people with Alzheimer's disease. The relationship between magnitude and variability of risperidone and 9-hydroxy risperidone exposure and the relationship with time to discontinuation of the medication were explored.
Link:	./index.php?lvl=notice_display&id=29416